Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Pittenger

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 4, 2023
5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in miceSarah J Jefferson, Ian Gregg, Mark Dibbs, et al.
Journal of Affective Disorders|February 27, 2016
OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor bindingChristopher Pittenger, Thomas G Adams, Jean-Dominique Gallezot, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Beta bursts mediate amygdala gating of hippocampal emotional encodingYajun Zhou, Yuqing Huang, Giana Pittaro, et al.
Frontiers in Psychiatry|May 14, 2023
Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialTerence H W Ching, Rachael Grazioplene, Calvin Bohner, et al.
Frontiers in Psychiatry|January 24, 2024
Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsTerence H W Ching, Lucia Amoroso, Calvin Bohner, et al.
Frontiers in Psychiatry|March 4, 2024
Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsTerence H W Ching, Lucia Amoroso, Calvin Bohner, et al.
Elife|July 27, 2021
Mapping brain-behavior space relationships along the psychosis spectrumJie Lisa Ji, Markus Helmer, Clara Fonteneau, et al.
Schizophrenia Bulletin|June 12, 2023
Pleiotropic Association of CACNA1C Variants With Neuropsychiatric DisordersZuxing Wang, Xiandong Lin, Xinqun Luo, et al.
Elife|April 5, 2022
Correction: Mapping brain-behavior space relationships along the psychosis spectrumJie Lisa Ji, Markus Helmer, Clara Fonteneau, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|February 28, 2026
Threading the needle: Practical considerations for merging theory-driven computational psychiatry with data-driven analytics to enhance precision health at scaleAnnie Cheng, Anna Konova, Albert Powers, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 4, 2023
5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in miceSarah J Jefferson, Ian Gregg, Mark Dibbs, et al.
Journal of Affective Disorders|February 27, 2016
OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor bindingChristopher Pittenger, Thomas G Adams, Jean-Dominique Gallezot, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Beta bursts mediate amygdala gating of hippocampal emotional encodingYajun Zhou, Yuqing Huang, Giana Pittaro, et al.
Frontiers in Psychiatry|May 14, 2023
Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialTerence H W Ching, Rachael Grazioplene, Calvin Bohner, et al.
Frontiers in Psychiatry|January 24, 2024
Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsTerence H W Ching, Lucia Amoroso, Calvin Bohner, et al.
Frontiers in Psychiatry|March 4, 2024
Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsTerence H W Ching, Lucia Amoroso, Calvin Bohner, et al.
Elife|July 27, 2021
Mapping brain-behavior space relationships along the psychosis spectrumJie Lisa Ji, Markus Helmer, Clara Fonteneau, et al.
Schizophrenia Bulletin|June 12, 2023
Pleiotropic Association of CACNA1C Variants With Neuropsychiatric DisordersZuxing Wang, Xiandong Lin, Xinqun Luo, et al.
Elife|April 5, 2022
Correction: Mapping brain-behavior space relationships along the psychosis spectrumJie Lisa Ji, Markus Helmer, Clara Fonteneau, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|February 28, 2026
Threading the needle: Practical considerations for merging theory-driven computational psychiatry with data-driven analytics to enhance precision health at scaleAnnie Cheng, Anna Konova, Albert Powers, et al.
Pageof 19